Your browser doesn't support javascript.
loading
Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation.
Grenald, Shaness A; Doyle, Timothy M; Zhang, Hong; Slosky, Lauren M; Chen, Zhoumou; Largent-Milnes, Tally M; Spiegel, Sarah; Vanderah, Todd W; Salvemini, Daniela.
Afiliação
  • Grenald SA; Department of Pharmacology, University of Arizona, Tucson, AZ, USA.
  • Doyle TM; Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO, USA.
  • Zhang H; Department of Pharmacology, University of Arizona, Tucson, AZ, USA.
  • Slosky LM; Department of Pharmacology, University of Arizona, Tucson, AZ, USA.
  • Chen Z; Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO, USA.
  • Largent-Milnes TM; Department of Pharmacology, University of Arizona, Tucson, AZ, USA.
  • Spiegel S; Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USA.
  • Vanderah TW; Department of Pharmacology, University of Arizona, Tucson, AZ, USA.
  • Salvemini D; Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO, USA.
Pain ; 158(9): 1733-1742, 2017 Sep.
Article em En | MEDLINE | ID: mdl-28570482

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Serina Endopeptidases / Inflamação Neurogênica / Pró-Proteína Convertases / Receptores de Lisoesfingolipídeo / Dor do Câncer Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Serina Endopeptidases / Inflamação Neurogênica / Pró-Proteína Convertases / Receptores de Lisoesfingolipídeo / Dor do Câncer Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2017 Tipo de documento: Article